Mechanism of Shenyuan Yiqi Huoxue Capsule on mitochondrial metabolic disorder in patients with unstable angina pectoris: randomized, single blind, group controlled clinical trial

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. The age range from 18 to 85 years old;
•2. Diagnosis of unstable angina pectoris, TCM syndrome differentiation belongs to Qi deficiency and blood stasis, and Angina pectoris occurred recently.
•3. Had a clear history of myocardial infarction or coronary revascularization, or at least one coronary artery stenosis was more than 75% (non left main artery disease) or more than 50% left main artery stenosis confirmed by coronary CTA or coronary angiography, and refused interventional treatment.
•4. Agree to participate in the clinical trial and sign the informed consent.

•1. Acute or subacute myocardial infarction.
•2. Severe cardiopulmonary insufficiency and severe impairment of liver and kidney function.
•3. Dementia and cognitive impairment.
•4. Taking other traditional Chinese medicine preparations.
•5. Allergic constitution or history of drug allergy.
•6. Other clinical researchers in recent 3 months.
•7. Used any preparation containing the same ingredients as this drug within 2 weeks.
•8. In pregnancy and lactation period, or have recent reproductive needs.

发起方

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University